Back
Aclaris Therapeutics Vs. Puma Biotechnology Industry Stock Comparison
Sell
11
ACRS
Aclaris Therapeutics
Last Price:
1.22
Seasonality Move:
4.39%
Sell
45
PBYI
Puma Biotechnology
Last Price:
5.04
Seasonality Move:
29.48%
Sell
11
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.22. The Score for ACRS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Puma Biotechnology (PBYI)
is a Sell
Is Puma Biotechnology a Buy, Sell or Hold?
- The current Puma Biotechnology [PBYI] share price is $5.02. The Score for PBYI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PBYI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.22
The current trend is relatively stagnant and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
PBYI Stock Price Chart
What is Puma Biotechnology's stock price today?
-
The Puma Biotechnology share price today is $5.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBYI is experiencing slight selling pressure.
ACRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 51.41 | Buy |
Chaikin Money Flow: | 633433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.24) | Buy |
Bollinger Bands (100): | (1.07 - 1.27) | Buy |
PBYI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 44.53 | Sell |
Chaikin Money Flow: | -60107 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.04 - 5.56) | Sell |
Bollinger Bands (100): | (4.34 - 5.9) | Sell |
ACRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.21 | Buy |
20-day SMA: | 1.21 | Buy |
50-day SMA: | 1.22 | Sell |
200-day SMA: | 3.72 | Sell |
8-day EMA: | 1.21 | Buy |
20-day EMA: | 1.21 | Buy |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 3.6 | Sell |
PBYI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.01 | Buy |
20-day SMA: | 5.26 | Sell |
50-day SMA: | 5.5 | Sell |
200-day SMA: | 4.18 | Buy |
8-day EMA: | 5.04 | Sell |
20-day EMA: | 5.17 | Sell |
50-day EMA: | 5.26 | Sell |
200-day EMA: | 4.5 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Puma Biotechnology Earnings Growth & PBYI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.02 per share.
Aclaris Therapeutics Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Puma Biotechnology Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |